Tralokinumab Plus Topical Corticosteroids as Needed Provides Progressive and Sustained Efficacy in Adults with Moderate-to-Severe Atopic Dermatitis Over a 32-Week Period: An ECZTRA...

por Silverberg, Jonathan I., Adam, David N., Zirwas, Matthew, Kalia, Sunil, Gutermuth, Jan, Pinter, Andreas, Pink, Andrew E., Chiricozzi, Andrea, Barbarot, Sebastien, Mark, Thomas, Tindberg, Ann-Marie, Weidinger, Stephan
Publicado 2022

Tralokinumab Efficacy Over 1 Year in Adults with Moderate-to-Severe Atopic Dermatitis: Pooled Data from Two Phase III Trials

por Simpson, Eric L., Pink, Andrew E., Blauvelt, Andrew, Gooderham, Melinda, Armstrong, April W., Worm, Margitta, Katoh, Norito, Peris, Ketty, Puig, Luis, Barbarot, Sébastien, Mark, Thomas, Steffensen, Louise Abildgaard, Tindberg, Ann-Marie, Wollenberg, Andreas
Publicado 2023